This effort is critical for understanding the action of PEDF on DED, because small synthetic peptides containing the active core domain may exclude potential interference from other domains of PEDF in vivo and increase the ability of the drug to diffuse into the dry eye boundary.18 The gene discussed is SERPINF1; the disease is Keratoconjunctivitis sicca.